Drug kills prostate tumor cells

August 11, 2006

U.S. scientists have developed an experimental RNA-based drug -- the first of its kind -- that kills prostate cancer cells, without harming normal cells.

The drug, developed at Duke University Medical Center, uses a type of genetic material, called targeting RNA, to enter cancer cells, and then another type, called silencing RNA, to stop the expression of a protein that keeps the cells alive.

In tests in mice with prostate cancer, the drug shrank the size of their tumors by half, while tumors in control mice continued to grow, said study co-author Bruce Sullenger, director of Duke's Translational Research Institute and chief of the Division of Experimental Surgery.

The mice showed no side effects from the treatment, Sullenger said.

"This study represents the first step in creating an RNA-based drug for cancer," said lead author James McNamara, a postdoctoral fellow in experimental surgery. "It provides a 'proof of principle' that an entirely RNA-based drug can work with minimal side effects, and it shows it is possible to overcome many of the obstacles that have hampered the development of RNA-based drugs."

The study is reported in the current issue of Nature Biotechnology.

Copyright 2006 by United Press International

Related Stories

Recommended for you

Roboticists learn to teach robots from babies

December 1, 2015

Babies learn about the world by exploring how their bodies move in space, grabbing toys, pushing things off tables and by watching and imitating what adults are doing.

Getting into the flow on the International Space Station

December 1, 2015

Think about underground water and gas as they filter through porous materials like soil and rock beds. On Earth, gravity forces water and gas to separate as they flow through the ground, cleaning the water and storing it ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.